Avapritinib (AVA) is a breakthrough targeted therapy as the first potent inhibitor approved for gastrointestinal stromal tumors (GIST) with PDGFRA D842V mutations. It lacks convenient analytical ...

High-entropy alloys (HEAs) have attracted extensive attention in recent decades due to their unique chemical, physical, and mechanical properties. An in-depth understanding of the structure–property ...

Thermal barrier coatings (TBCs) are widely used in gas turbine engines to obtain elevated working temperatures and improve engine efficiency. The phase transition of the ceramic layer is accompanied ...

The downstream processing of virus particles, vesicles, RNAs, plasmids and other forms of DNA, contains multiple interdependent steps, each requiring optimization for best results. This webinar will ...

For decades, antibodies have been one of the crown jewels of modern medicine—powerful molecules that can neutralize viruses, tame autoimmune diseases, and revolutionize cancer care. Yet despite their ...

Lying between the infrared and millimeter wave regimes, terahertz waves possess many unique properties, prompting numerous compelling imaging applications, such as non-destructive testing, security ...

Developing new pharmaceuticals is a complex and costly process that requires innovation and efficiency. High-throughput immunoassays (HTIs) are an emerging technology poised to accelerate the drug ...

The electrical properties of cancer cells can provide information on their cancer type, state, and drug resistance. However, conventional platforms to measure these properties are complex and can only ...

A review maps high throughput strategies that link automation, microfluidics, and barcoding into a unified pipeline, enabling faster, more predictive lipid nanoparticle development for genetic ...

Researchers at the University of Basel are able to test in parallel the effects of over 1,500 active substances on cell metabolism. Their analysis also led to the discovery of previously unknown ...

Twice a year, influenza experts engage in a critically important forecasting bet: pick three to four vaccine strains now that will match the flu viruses people will face in 8-12 months. The strains ...

MicroAlgo Inc. (the 'Company' or 'MicroAlgo') (NASDAQ: MLGO), today announced the development of an innovative high-precision, high-throughput reconfigurable simulation technology, aimed at providing ...